The CDC73 antibody is a laboratory tool designed to detect and study the CDC73 protein (parafibromin), a tumor suppressor encoded by the CDC73 gene. This protein plays critical roles in transcriptional regulation as part of the PAF1 complex, which associates with RNA polymerase II and histone-modifying enzymes . CDC73 mutations are linked to hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid carcinomas, making its detection vital for both research and clinical diagnostics .
CDC73 antibodies are widely used in molecular and cellular biology for:
Western blotting (WB): Detecting endogenous CDC73 protein (~60–61 kDa) .
Immunoprecipitation (IP): Isolating CDC73 and its interacting partners (e.g., CPSF, CstF complexes) .
Immunohistochemistry (IHC): Assessing CDC73 expression in tumor tissues .
Immunofluorescence (IF): Localizing CDC73 within the nucleus or cytoskeleton .
CDC73 interacts with CPSF and CstF complexes, facilitating mRNA 3′ processing and transcriptional elongation .
Depletion of CDC73 reduces recruitment of CPSF/CstF subunits to gene loci (e.g., INTS6), impairing mRNA maturation .
CDC73 loss correlates with tumor aggressiveness in breast, gastric, and colorectal cancers .
Storage: Stable at -20°C in PBS with 0.02% sodium azide and 50% glycerol .
Validation: Verified via siRNA knockdown, immunoprecipitation, and mass spectrometry .
Cross-reactivity: Confirmed in human, mouse, rat, and monkey tissues .
Current research focuses on: